Population screening of asymptomatic persons with Epstein–Barr virus (EBV) DNA or antibodies has improved the diagnosis of nasopharyngeal carcinoma and survival among affected persons. However, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results